Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Balance is a pH-neutral peritoneal dialysis solution developed by Fresenius Medical Care. It is designed to provide a more biocompatible alternative to conventional acidic dialysis fluids by utilizing a dual-chamber system that separates glucose from the buffer during sterilization, thereby minimizing the formation of glucose degradation products (GDPs). Upon mixing before administration, the solution achieves a physiological pH. It contains glucose as an osmotic agent to remove excess water and toxins from the blood across the peritoneal membrane, along with essential electrolytes and a lactate buffer to correct metabolic acidosis in patients with chronic kidney failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on balance.